NASDAQ:TNDM

Tandem Diabetes Care Price Target, Predictions & Analyst Ratings

$104.99
-1.63 (-1.53 %)
(As of 08/3/2021 12:00 AM ET)
Add
Compare
Today's Range
$104.48
$107.57
50-Day Range
$83.72
$108.67
52-Week Range
$76.19
$123.74
Volume507,244 shs
Average Volume666,538 shs
Market Capitalization$6.58 billion
P/E RatioN/A
Dividend YieldN/A
Beta0.27

Tandem Diabetes Care (NASDAQ:TNDM) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
7 Wall Street analysts have issued ratings and price targets for Tandem Diabetes Care in the last 12 months. Their average twelve-month price target is $119.71, predicting that the stock has a possible upside of 14.02%. The high price target for TNDM is $150.00 and the low price target for TNDM is $90.00. There are currently 1 sell rating, 2 hold ratings and 4 buy ratings for the stock, resulting in a consensus rating of "Hold."
TypeToday30 Days Ago90 Days Ago180 Days Ago
TNDM Consensus Rating: HoldBuyBuyBuy
TNDM Consensus Rating Score: 2.432.642.752.64
TNDM Analyst Ratings: 1 Sell Rating(s)
2 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
2 Hold Rating(s)
8 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
9 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
5 Hold Rating(s)
9 Buy Rating(s)
0 Strong Buy Rating(s)
TNDM Consensus Price Target: $119.71$121.64$119.33$114.57
TNDM Price Target Upside: 14.02% upside21.69% upside19.33% upside15.88% upside

Tandem Diabetes Care (NASDAQ:TNDM) Consensus Price Target History

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Tandem Diabetes Care (NASDAQ:TNDM) Analyst Ratings History

DateBrokerageAnalyst NameActionRatingPrice TargetDetails
5/24/2021Barclays
Initiated CoverageUnderweight$90.00
5/6/2021Oppenheimer
Boost Price Target$130.00 ➝ $135.00
5/6/2021SVB Leerink
Boost Price TargetMarket Perform$95.00 ➝ $102.00
2/25/2021Lake Street Capital
Boost Price TargetBuy$137.00 ➝ $150.00
12/15/2020Wells Fargo & Company
DowngradeOverweight ➝ Equal Weight$105.00
11/6/2020Raymond James
Boost Price TargetOutperform$116.00 ➝ $124.00
11/6/2020Piper Sandler
Matthew O'Brien
Boost Price TargetOverweight$125.00 ➝ $132.00
7/31/2020Craig Hallum
Alexander Nowak
Boost Price TargetBuy$102.00 ➝ $140.00
7/31/2020Guggenheim
Christopher Pasquale
UpgradeNeutral ➝ Buy$130.00
7/7/2020Cowen
Ryan Blicker
Boost Price TargetPositive ➝ Outperform$85.00 ➝ $110.00
7/6/2020Citigroup
UpgradeNeutral ➝ Buy$94.00 ➝ $120.00
6/30/2020Bank of America
Travis Steed
Reiterated RatingHold$100.00
6/22/2020UBS Group
Boost Price TargetBuy$98.00 ➝ $106.00
5/1/2020Stifel Nicolaus
Boost Price TargetHold$65.00 ➝ $75.00
2/4/2020Robert W. Baird
DowngradeOutperform ➝ Neutral$71.00 ➝ $75.00
3/8/2019BMO Capital Markets
Initiated CoverageOutperform ➝ Outperform$77.00
2/27/2019Piper Jaffray Companies
UpgradeOverweight$67.00
9/26/2018Dougherty & Co
Boost Price TargetBuy$45.00 ➝ $56.00
8/30/2018Berenberg Bank
Initiated CoverageBuy ➝ Buy$50.00
(Data available from 8/3/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
This page was last updated on 8/3/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.